Previous research had shown that overexpression of HIF-1α has been observed in multiple types of tumors, such as liver cancer, breast cancer, brain cancer, BCa, and other tumor tissues, which can be regulated by tumor-related signaling. Here, HIF1A is linked to breast carcinoma.